CompletedNCT00399698
Risperidone and thinking, movement, and steadiness in children
About this title
Read the official source — NCT00399698Medication studyAges 4–14United StatesAdjustment disorder
Understand this study
Who was this study for?
Listed age limits: 4 years to 14 years.
- Listed locations
- ColumbusSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateMay 1999
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- Ohio State University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 4 Years to 14 Years
- Official registry ID
- NCT00399698
- Official title
Show the full official title
Effects of Risperidone on Cognitive-Motor Performance and Motor Movements in Chronically Medicated Children
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Columbus
Registry details
Registry conditions (original wording)
Oppositional Defiant Disorder; Conduct Disorder; Attention Deficit/Hyperactivity Disorder (ADHD); Intermittent Explosive Disorder; Impulse-Control Disorders; Adjustment Disorder; Bipolar Disorder; Pervasive Developmental Disorder
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Ohio State University, a university.
Did this study involve medication?
Yes. The study involved medication, including Risperdal.
Who was this study for?
Listed age limits: 4 years to 14 years.
